0001140361-12-034377.txt : 20120731 0001140361-12-034377.hdr.sgml : 20120731 20120731103342 ACCESSION NUMBER: 0001140361-12-034377 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20120731 DATE AS OF CHANGE: 20120731 EFFECTIVENESS DATE: 20120731 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vedantra Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001555192 IRS NUMBER: 452966790 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-181991 FILM NUMBER: 12995639 BUSINESS ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-360-9995 MAIL ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0706 D LIVE 0001555192 Vedantra Pharmaceuticals, Inc. ONE BROADWAY 14th FLOOR CAMBRIDGE MA MASSACHUSETTS 02142 617-360-9995 DELAWARE None None Corporation true 2011 Alan Shaw c/o Access BridgeGap, LLC One Broadway, 14th Floor Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Promoter Ben Bronstein c/o Access BridgeGap, LLC One Broadway, 14th Floor Cambridge MA MASSACHUSETTS 02142 Director Daniel Behr c/o Access BridgeGap, LLC 730 Fifth Avenue New York NY NEW YORK 10019 Director Biotechnology Decline to Disclose 06 false 2012-07-18 false true false 0 5000000 3300000 1700000 Series A Convertible Redeemable Preferred Stock false 1 0 0 0 true false Vedantra Pharmaceuticals, Inc. /s/ Alan Shaw Alan Shaw Chief Executive Officer 2012-07-31